These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 9509412

  • 1. Characterization of a mitochondrial DNA deletion in patients with mitochondrial myopathy.
    Kim SH, Chi JG.
    Mol Cells; 1997 Dec 31; 7(6):726-9. PubMed ID: 9509412
    [Abstract] [Full Text] [Related]

  • 2. Quantitative analysis of mitochondrial DNA deletion in paraffin embedded muscle tissues from patients with KSS and CPEO.
    Kim SH, Chi JG, Reith A, Kadenbach B.
    Biochim Biophys Acta; 1997 May 24; 1360(3):193-5. PubMed ID: 9197460
    [Abstract] [Full Text] [Related]

  • 3. Detection and characterization of mitochondrial DNA rearrangements in Pearson and Kearns-Sayre syndromes by long PCR.
    Kleinle S, Wiesmann U, Superti-Furga A, Krähenbühl S, Boltshauser E, Reichen J, Liechti-Gallati S.
    Hum Genet; 1997 Oct 24; 100(5-6):643-50. PubMed ID: 9341886
    [Abstract] [Full Text] [Related]

  • 4. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy.
    Sciacco M, Bonilla E, Schon EA, DiMauro S, Moraes CT.
    Hum Mol Genet; 1994 Jan 24; 3(1):13-9. PubMed ID: 8162014
    [Abstract] [Full Text] [Related]

  • 5. The clinical, myopathological, and genetic analysis of 155 Chinese mitochondrial ophthalmoplegia patients with mitochondrial DNA single large deletions.
    Zhao Y, Hou Y, Zhao X, Liufu T, Yu M, Zhang W, Xie Z, Zhang VW, Yuan Y, Wang Z.
    Mol Genet Genomic Med; 2024 Jan 24; 12(1):e2328. PubMed ID: 38018320
    [Abstract] [Full Text] [Related]

  • 6. Specific detection of deleted mitochondrial DNA by in situ hybridization using a chimera probe.
    Nakamura N, Hattori N, Tanaka M, Mizuno Y.
    Biochim Biophys Acta; 1996 Sep 11; 1308(3):215-21. PubMed ID: 8809113
    [Abstract] [Full Text] [Related]

  • 7. Ophthalmoplegia in Mitochondrial Disease.
    Lee SJ, Na JH, Han J, Lee YM.
    Yonsei Med J; 2018 Dec 11; 59(10):1190-1196. PubMed ID: 30450853
    [Abstract] [Full Text] [Related]

  • 8. Efficient and specific amplification of identified partial duplications of human mitochondrial DNA by long PCR.
    Fromenty B, Manfredi G, Sadlock J, Zhang L, King MP, Schon EA.
    Biochim Biophys Acta; 1996 Sep 11; 1308(3):222-30. PubMed ID: 8809114
    [Abstract] [Full Text] [Related]

  • 9. Recognition of mitochondrial DNA deletion syndrome with non-neuromuscular multisystemic manifestation.
    Wong LJ.
    Genet Med; 2001 Sep 11; 3(6):399-404. PubMed ID: 11715003
    [Abstract] [Full Text] [Related]

  • 10. [Mitochondrial DNA mutations in patients with chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome].
    Wang ZX, Yuan Y, Gao F, Qi Y, Shen DG, Chen QT.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Aug 11; 20(4):273-8. PubMed ID: 12903032
    [Abstract] [Full Text] [Related]

  • 11. [Progressive external ophthalmoplegia and the Kearns-Sayre syndrome: a clinical and molecular study of 6 cases].
    Barrientos A, Casademont J, Grau JM, Cardellach F, Montoya J, Estivill X, Urbano-Márquez A, Nunes V.
    Med Clin (Barc); 1995 Jul 01; 105(5):180-4. PubMed ID: 7630231
    [Abstract] [Full Text] [Related]

  • 12. Deletions of mitochondrial DNA in Kearns-Sayre syndrome and ocular myopathies: genetic, biochemical and morphological studies.
    Degoul F, Nelson I, Lestienne P, Francois D, Romero N, Duboc D, Eymard B, Fardeau M, Ponsot G, Paturneau-Jouas M.
    J Neurol Sci; 1991 Feb 01; 101(2):168-77. PubMed ID: 1851820
    [Abstract] [Full Text] [Related]

  • 13. Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes.
    Sadikovic B, Wang J, El-Hattab AW, Landsverk M, Douglas G, Brundage EK, Craigen WJ, Schmitt ES, Wong LJ.
    PLoS One; 2010 Dec 20; 5(12):e15687. PubMed ID: 21187929
    [Abstract] [Full Text] [Related]

  • 14. Chronic progressive external ophthalmoplegia: a correlative study of quantitative molecular data and histochemical and biochemical profile.
    Fassati A, Bordoni A, Amboni P, Fortunato F, Fagiolari G, Bresolin N, Prelle A, Comi G, Scarlato G.
    J Neurol Sci; 1994 May 20; 123(1-2):140-6. PubMed ID: 8064307
    [Abstract] [Full Text] [Related]

  • 15. Zidovudine and dideoxynucleosides deplete wild-type mitochondrial DNA levels and increase deleted mitochondrial DNA levels in cultured Kearns-Sayre syndrome fibroblasts.
    Wang H, Lemire BD, Cass CE, Weiner JH, Michalak M, Penn AM, Fliegel L.
    Biochim Biophys Acta; 1996 May 24; 1316(1):51-9. PubMed ID: 8634344
    [Abstract] [Full Text] [Related]

  • 16. Early retinal involvement in mitochondrial myopathy with mitochondrial DNA deletion.
    Ota Y, Miyake Y, Awaya S, Kumagai T, Tanaka M, Ozawa T.
    Retina; 1994 May 24; 14(3):270-6. PubMed ID: 7973124
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Chronic progressive external ophthalmoplegia (CPEO); mitochondrial DNA deletion, brain MRI and electrophysiological studies].
    Nakagawa M, Tokimura M, Kuriyama M, Higuchi I, Osame M.
    Rinsho Shinkeigaku; 1991 Sep 24; 31(9):981-6. PubMed ID: 1769162
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MELAS- and Kearns-Sayre-type co-mutation [corrected] with myopathy and autoimmune polyendocrinopathy.
    Ohno K, Yamamoto M, Engel AG, Harper CM, Roberts LR, Tan GH, Fatourechi V.
    Ann Neurol; 1996 Jun 24; 39(6):761-6. PubMed ID: 8651648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.